                                                                                                                           REVIEW ARTICLE
                                                                                                                              published: 09 July 2014
                                                                                                                      doi: 10.3389/fnmol.2014.00064



Interaction LRRK2 kinase GTPase signaling
cascades
Joon Y. Boon1 , Julien Dusonchet 1 , Chelsea Trengrove1 Benjamin Wolozin1,2 *
1
    Department Pharmacology Experimental Therapeutics, Boston University School Medicine, Boston, MA, USA
2
    Neurology, Boston University School Medicine, Boston, MA, USA



Edited                                LRRK2 protein interacts plethora signaling molecules, complexity
Jean-Marc Taymans, KU Leuven,            LRRK2 function presents challenge understanding role LRRK2 Belgium
                                         pathophysiology Parkinsonâ€™s disease (PD). Studies LRRK2 using expression Reviewed 
R. Jeremy Nichols, Parkinsonâ€™s
                                         transgenic mice disappointing,  studies using invertebrate systems
Institute, USA                           yielded clearer picture, clear effects LRRK2 expression, knockdown
Patrick Lewis, University College        deletion Caenorhabditis elegans Drosophila modulation survival London, UK                               dopaminergic neurons. Recent studies begun focus attention particular signaling
*Correspondence:                         cascades target LRRK2 function. LRRK2 interacts members Benjamin Wolozin, Department Pharmacology Experimental
                                         mitogen activated protein kinase (MAPK) pathway regulate pathway action
Therapeutics, Boston University          acting scaffold directs location MAPK pathway activity, strongly
School Medicine, 72 East Concord      affecting MAPK pathway activity. Binding GTPases, GTPase-activating
Street, R614, Boston,                    proteins GTPase exchange factors strong theme LRRK2 biology, MA 02118-2526, USA
e-mail: bwolozin@bu.edu
                                         LRRK2 binding rac1, cdc42, rab5, rab7L1, endoA, RGS2, ArfGAP1, ArhGEF7.
                                         molecules appear feed function output LRRK2 modulates
                                         cytoskeletal outgrowth vesicular dynamics, including autophagy. functions likely
                                         impact modulation Î±-synuclein aggregation associated toxicity eliciting disease
                                         processes term PD.
                                          Keywords: GTPase, kinase, trafficking, cytoskeleton, actin, autophagy, cell death, dopamine



INTRODUCTION                                                                    protein (RIP) kinase families. common mutation Parkinsonâ€™s disease (PD) common age-related motor                   LRRK2 associated PD G2019S mutation located disorder (Hsu et al., 2010a; Ferree et al., 2012). Accumulation              kinase domain LRRK2 (Wszolek et al., 2004; Zimprich
aggregated Î±-synuclein form Lewy bodies neuropathologi-                 et al., 2004). common amino acid substitution include
cal hallmark PD (Lees et al., 2009). Mutations leucine-rich              R1441C/G/H Roc GTPase domain Y1699C COR
repeat kinase 2, LRRK2, gene common genetic determinants                 domain (Taylor et al., 2006). pathological mutations G2019S
PD, 20 different mutations identiï¬?ed date causing              enhances kinase activity affecting GTPase activ-
late-onset, familial autosomal-dominant PD (Gasser et al., 2011;                ity LRRK2; R1441C/G/H Y1699C affect GTPase
Greene, 2012). prevalent amino acid substitution muta-                 activity LRRK2 impairing GTP hydrolysis inconsis-
tion LRRK2, G2019S, 1â€“2  sporadic PD                    tent effects kinase activity (West et al., 2005; Greggio et al.,
cases; sporadic PD LRRK2-associated PD clinically                2006; Ito et al., 2007; Lewis et al., 2007; Li et al., 2007).  neurochemically indistinguishable (Healy et al., 2008).               underlying mechanisms linking mutations pathology indicate LRRK2 important role pathogenesis               remain unclear. PD.
    LRRK2 large ubiquitous cytoplasmic protein consisting                  LRRK2 MODULATES SURVIVAL DOPAMINERGIC 2527 amino acids multiple functional domains (Cook-                     NEURONS, AUTOPHAGY, NEURONAL OUTGROWTH
son, 2010). LRRK2 homolog mammals, termed LRRK1;                       Studies LRRK2 using expression transgenic mice LRRK1 2 expression appear complementary,                         disappointing, studies showing consistent effects
LRRK2 expression peaking development decreases rapidly                   occurring expression wildtype mutant LRRK2 birth, LRRK2 expression increases postnatally (Simon-               (Dawson et al., 2010). Knockout LRRK2 mouse yielded
Sanchez et al., 2006). LRRK2 protein consists kinase,                    strong phenotype kidney pointing role LRRK2 Ras complex proteins (ROCs) GTPase, C-terminal ROC                        autophagy,  clear differences brain; sug-
(COR), leucine-rich repeat, ankyrin WD40 domains (Cook-                     gests mammalian LRRK2 vivo models better job
son, 2010). catalytic domains kinase ROC                    modeling cellular function/dysfunction provid-
GTPase domains. kinase domain highest sequence                      ing general model PD (Tong et al., 2010). contrast,
homology mitogen-activated protein kinase kinase kinase                      expression studies using invertebrate systems yielded
(MKKK)/MLKs (mixed lineage kinases) receptor-interacting                    clearer results. Orthologs LRRK2 exist Drosophila



Frontiers Molecular Neuroscience                                 www.frontiersin.org                                      July 2014 | Volume 7 | Article 64 | 1
Boon et al.                                                                                                  LRRK2 regulator cellular signaling



 Nematodes, species exhibit just form                detrimental. general, data suggest loss LRRK2 LRRK, referred lrk-1 (Marin, 2008). invertebrate              expression detrimental.
LRRK2 orthologs kinase, COR ROC domains homologous mammalian LRRK2, lrk-1 protein appears               LRRK2 REGULATES MAP KINASE SIGNALING PATHWAYS subsume functions LRRK1 LRRK2 (Marin,                   Incorporating research multiple different venues suggests
2008; Saha et al., 2009). Studies groups examin-              roles LRRK2 differing cellular networks. Prior studies
ing effects LRRK2 expression, knockdown deletion              laboratory, subsequent studies Kahle lab-
Caenorhabditis elegans Drosophila strong effects (Liu         oratory indicate LRRK2 interacts mitogen activated
et al., 2008; Wang et al., 2008; Saha et al., 2009; Samann et al., 2009;   protein kinase (MAPK) pathways (Carballo-Carbajal et al., 2010;
Venderova et al., 2009; Yao et al., 2010; Yuan et al., 2011).          Hsu et al., 2010a,b). MAPK pathway signaling network
results appear differ somewhat based              begins membrane signaling extends mul-
effects strong cases. Studies laboratory indicate        tiple successive kinases leading ultimately phosphorylation expressing WT LRRK2 promotes survival dopaminergic                 transcription factors act gene expression (Yang et al., 2013).
neurons response rotenone treatment, mutant LRRK2                 Receptor signaling frequently begins MAP Kinase kinase
(G2019S R1441C) enhances loss dopaminergic neurons rel-              kinases (MAPKKKs, termed mixed lineage kinases, MLKs),
ative WT (Saha et al., 2009). important aspect           enzymes act initiate signaling cascades ulti-
observations, important considering studies             mately lead transcriptional regulation (Yang et al., 2013). LRRK2 generally, G2019S potentiates loss           MLK family kinases activates c-jun NH2-terminal kinase
neuronal processes relative WT LRRK2. nematodes                 (JNK) pathway phosphorylating MKK4 -7 activates
lack endogenous Î±-synuclein, recently crossed LRRK2                 p38 pathway phosphorylating MKK3 -6 (Gallo lines line expressing Î±-synuclein dopaminergic neurons.            Johnson, 2002; Wang et al., 2004). stress kinase complexes
Interestingly, current studies new nematode model            required scaffold proteins regulation subcellular
laboratory shows WT G2019S LRRK2 potentiate                  localization. particular MAP kinase signaling cascades,
age-related loss dopaminergic neurons  processes),         JNK-interacting proteins (JIPs) group scaffold pro-
suggesting understanding interaction LRRK2                teins regulation (Kelkar et al., 2005; Whitmarsh, 2006). Î±-synuclein important modeling pathophysiol-                 MKKs recruited multi-protein com-
ogy PD. Studies Chen laboratory using different              plex scaffold proteins JIPs (Habig et al., 2013). JIP1-3 regulates
C. elegans model  incorporation Î±-synuclein)             speciï¬?city localization JNK pathway JIP4 deleterious effect WT G2019S LRRK2, studies using             speciï¬?c scaffolding protein p38 pathway (Verhey et al.,
Drosophila indicate LRRK2 potentiates degeneration reti-           2001; Kelkar et al., 2005; Whitmarsh, 2006).
nal cells loss dopaminergic neurons (Liu et al., 2008; Yao              Multiple studies LRRK2 interacts MAPK
et al., 2010).  speciï¬?c results depend particular          pathway kinase domain homologous MAP-
model used, clear invertebrate models sen-         KKK/MLKs RIPs (West et al., 2005; Greggio Cookson,
sitive modulation LRRK2 levels, mutations LRRK2               2009; Carballo-Carbajal et al., 2010; Hsu et al., 2010a,b). 
potentiate degeneration dopaminergic neurons. mouse               studies suggest LRRK2 strong activator
models particularly sensitive LRRK2 expression,            pathway. laboratory shown LRRK2 binds
knockout LRRK2 appears potentiate autophagic deï¬?cits              MKK6, -3, -7 HEK293FT (Gloeckner et al., 2009; Hsu kidney, site normally exhibits strong expres-          et al., 2010a). Binding LRRK2 MKK6, -3, -7, acti-
sion LRRK2. provides evidence effects observed            vates p38 JNK pathway, activation invertebrate systems strong relevance mammalian           strikingly modest (Hsu et al., 2010a). Receptor activation                                                                     MAPK pathway produces fold increases activ-
    Studies using primary rodent neurons grown culture             ities downstream kinases, expressing LRRK2
yielded stronger results transgenic mouse mod-               increases activities kinases downstream transcrip-
els. studies consistently indicate expression mutant         tion factors 60  (Hsu et al., 2010a). Studies LRRK2 potentiates neurodegeneration, reduces neurite               Kahle laboratory showed similarly low levels kinase acti-
growth (Smith et al., 2005; Chan et al., 2011; Skibinski et al., 2014).    vation LRRK2 expression (Carballo-Carbajal et al.,
Interestingly, acute expression WT LRRK2 appears bene-            2010). studies showed LRRK2 upregulates alpha-
ï¬?cial, parallels observations studies C. elegans.        synuclein transcription parallel MEK/ERK activation. study, using utero electroporation LRRK2 rodent           induction transcriptional upregulation alpha-synuclein brain observed detrimental effects G2019S LRRK2                suppressed treatment selective MAPK/ERK kinase
beneï¬?cial effects WT LRRK2, suggesting acute expres-               inhibitor, U0126 (Carballo-Carbajal et al., 2010). Disease linked
sion LRRK2 rodent brain produce clearer results            mutations increased activation additional 25â€“30 . chronic expression, occurs transgenic mice          Similar results observed analysis JIP proteins,
(Macleod et al., 2006). Taken  results indicate        act scaffolds MAPKs, function transport mutant LRRK2 detrimental; effects WT LRRK2              MAPKs (Hsu et al., 2010b). shown LRRK2
clear, data suggesting WT LRRK2 beneï¬?cial,               binds JIP1-4 associated increased levels total data suggesting expression mildly               JIP1, -3, -4, oligomeric JIP, ubiquitinated JIP. addition,



Frontiers Molecular Neuroscience                            www.frontiersin.org                                July 2014 | Volume 7 | Article 64 | 2
Boon et al.                                                                                                 LRRK2 regulator cellular signaling




G2019S, R1441C I2020T  Y1699C) mutations                  modulating neuronal development function, inï¬‚uencing
LRRK2 increased binding MKK6 levels JIP4 (Hsu           dopamine signaling synaptogenesis (Parisiadou et al., 2014).
et al., 2010b). stimulation JIP oligomerization partic-       R1441C LRRK2 mutation exhibits similar neuronal effects ularly striking effect observed expression LRRK2         LRRK2 knockout mice, causing dopamine signaling impairments
JIPs.                                                                    neurite retraction enhanced PKA activation. PKA     Despite relatively modest effect LRRK2 MAPK            regulates LRRK2 phosphorylating S1444 ROC domain;
cascades, LRRK2 produces robust effect vivo, MAPKs          14-3-3 binds phospho-serine 1444 inhibits LRRK2
appear necessary function. vivo studies C.      kinase activity (Muda et al., 2014). Binding 14-3-3 differ-
elegans showed robust protection mitochondrial stress       ent phospho-epitopes (Ser-910/935) appears stabilize LRRK2, induced LRRK2 expression. protection depen-              reduced binding destabilizes LRRK2 causes aggregation
dent action MKK6 p38 RNAi knockdown              LRRK2 form cytoplasmic inclusions (Dzamko et al., 2010).
endogenous orthologs MKK6 P38 (sek-1 pmk-1) dele-           Identiï¬?cation targets LRRK2 kinase activity remains unclear.
tion sek-1 C. elegans abolish neuroprotection LRRK2 (Hsu        Studies identiï¬?ed numerous putative substrates, including
et al., 2010a). MAPK cascade appears modulate            MAPK, 4E-BP, Tau (Imai et al., 2008; Berwick Harvey,
effects LRRK2 autophagy (Plowey et al., 2008). Using redox         2011; Bailey et al., 2013).
proteomics, demonstrated LRRK2 regulates proteins               LRRK2 gained attention putative
associated lysosome, including ATPVA6 (Di Domenico              role modulating dopamine function, LRRK2 exerts regu-
et al., 2012). Application MAPKK (MEK) inhibitor blocked        lation immune responses. LRRK2 inhibits transcription
effects LRRK2 autophagy neurite shortening (Plowey          factor NFAT, plays important roles immune function et al., 2008).  interactions LRRK2 members           inï¬‚ammatory bowel disease (Liu et al., 2011).  MAPK pathway cause signiï¬ physiological effects despite          expression LRRK2, NFAT remains cytosolic, unable causing modest changes phosphorylation.                          translocate nucleus, suppresses transcriptional
    discordance modest effects LRRK2 acti-         activity (Liu et al., 2011). MyD88 pathway additional
vation MAPK pathway strong effects LRRK2            pathway associated role LRRK2 immune
protecting dopaminergic neurons nematode, strong           function. inï¬‚ammation, TLR signaling MyD88 path-
effect LRRK2 JIP oligomerization demands novel model             way leads phosphorylation LRRK2, implicating LRRK2 explain LRRK2 function. possibility LRRK2 acts            macrophage biology (Dzamko et al., 2012). scaffold directs location MAPK pathway activity, strongly affecting MAPK pathway activ-             LRRK2 REGULATES SMALL GTPases
ity. Location important enzymatic action           repeating theme LRRK2 biology interactions small
activity. JIPs instance, thought function vesicular        GTPases. ROC domain LRRK2 striking forms
trafï¬?cking. LRRK2 exhibited role vesicular trafï¬?cking,      homo- hetero- dimers LRRK2 LRRK2, respectively, impact neuronal function directing particular        vitro (Shin et al., 2008; Hsu et al., 2010a; Kumar et al., 2010). enzymes trafï¬?cked vesicles, explicitly activat-       tendency LRRK2 ROC domain dimerize appears belie ing MAPK pathway. role consistent          broader biological characteristic, ability bind multi- studies suggesting function LRRK2 regulating small        ple small GTPases. described  shown LRRK2
GTPases associated vesicles.                                        binds small GTPase, rac1 (Chan et al., 2011). observation
                                                                         parallels studies showing LRRK2 binds func-
LRRK2 REGULATES SIGNALING CASCADES                            tionally dependent small GTPases, rab5, rab7L1
Recent transcriptome proteome studies emphasize diverse          endoA (Matta et al., 2012; Beilina et al., 2014). Additionally,
number pathways regulated LRRK2. Studies Dawson             LRRK2 binds multiple GTP modulating proteins (described fol-
group recently highlighted regulation translational functions         lowing sections). case rac1, interactions LRRK2 LRRK2, showing LRRK2 binds phosphorylates             appears regulate site action small GTPase, ribosomal protein RPS15 (Martin et al., 2014). observation          leads strong effects cytoskeleton, arfGEF7, ï¬?ts studies showing roles LRRK2 negative        regulate growth cone (Habig et al., 2013).
mediator miR mediated translational repression (Gehrke et al.,            interaction LRRK2 rac1 observed 
2010). regulatory network developed identiï¬?es           immunoprecipitation. LRRK2 immunoprecipitate rac1
RPS15 primary member LRRK2 regulatory network,               expression cell lines (HEK293FT cells), interacting LRRK2 pathway includes ADP-ribose         endogenous human brain striatum; contrast binding polymerase TNKS (Dusonchet et al., 2014). Cookson group              Cdc42 weak binding RhoA apparent (Chan recently published proteomic study LRRK2, identi-        et al., 2011). Speciï¬?city interaction shown selective
ï¬?ed cyclin-G associated kinase (GAK) strong binding protein         precipitation rac1, precipitation classic
(Beilina et al., 2014). GAK strongest genetic risk factor   Rho GTPases â€“ Cdc42 RhoA, study did PD, synuclein tau (Pankratz et al., 2009; Dumitriu         ï¬?nd evidence interaction LRRK2 cdc42 (Chan et al.,
et al., 2011).                                                           2011; Habig et al., 2013). interaction LRRK2 rac1
    studies identify LRRK2 negative regulator              occurs ROCâ€“COR kinase domains. expressing
PKA signaling, acting direct interaction PKAR11B,           LRRK2 rac1 enhanced rac1 activity increasing binding



Frontiers Molecular Neuroscience                          www.frontiersin.org                                 July 2014 | Volume 7 | Article 64 | 3
Boon et al.                                                                                                   LRRK2 regulator cellular signaling



 rac1 p21-activated kinase, turn modulates actin              cell death pathways, presumably white blood cells cytoskeletal dynamics. LRRK2 inactivated kinase GTPase              post-mortem tissues. LRRK2-centered association sub-
domains does activate rac1 (Chan et al., 2011). LRRK2 does              network identiï¬?ed known interactors, novel increase membrane-bound rac1, signiï¬?cantly changes               linked pathways (Dusonchet et al., 2014). instance, network cellular localization rac1, causing polarization,              proteins previously associated LRRK2 augmented LRRK2 expressed                    present network, including DJ-1, PINK1, MKK7, JIP1
stitutively active rac1. G2019S R1441C LRRK2 mutations                  (Ho et al., 2009; Sancho et al., 2009; Carballo-Carbajal et al., 2010;
decrease rac1 binding; Y1699C I2020T increase rac1              Hsu et al., 2010a,b; Ferree et al., 2012; Dusonchet et al., 2014). binding.                                                                    network identiï¬?ed novel networks linked LRRK2.
    Rac1 known play important role actin cytoskele-             Subsequent studies validated putative roles interacting
ton remodeling required maintenance neurite              proteins using knockdown studies C. elegans.
morphology (Chan et al., 2011). interaction LRRK2                   Previous work laboratory established LRRK2 rac1 results distinct effects associated changes             expression protects dopaminergic neurons degeneration actin cytoskeleton. Previous studies shown G2019S             induced mitochondrial toxin, rotenone. tested induces neurite retraction vitro vivo studies             action putative network partners LRRK2 mediated pro- MAPK signaling pathway pathology pre-                  tection dopaminergic neurons, identiï¬?ed 280 genes
cedes dopaminergic neuronal death apoptosis (Liou et al., 2008;          knockdown modiï¬?ed effects LRRK2 dopamin-
Plowey et al., 2008; Parisiadou et al., 2009; Carballo-Carbajal et al.,     ergic neurons. Genes knockdown impaired LRRK2 action
2010; Hsu et al., 2010a,b). SH-SY5Y cells, expression rac1         included genes known LRRK2 network (DJ- G2019S shown rescue neurite retraction induced                1, PINK1, MKK7, JIP1), multiple genes,
G2019S. studies suggest mutations LRRK2 lead              including HDAC6, vps34 unc51, associated decrease activation rac1, causes disassembly            autophagy (Dusonchet et al., 2014). connection actin ï¬?laments leading neurite retraction (Chan et al., 2011).           LRRK2 autophagy consistent prior stud-
                                                                            ies, studies suggesting role LRRK2 vesicular
SYSTEMS BIOLOGY PROVIDES COMPREHENSIVE                                    biology (Biskup et al., 2006; Plowey et al., 2008; Alegre-Abarrategui
ASSESSMENT CELLULAR PATHWAYS INTERACTING                                 et al., 2009). LRRK2                                                                      particularly interesting proteins identiï¬?ed studies showing LRRK2 interacting varied cellular             network analysis signaling gene RGS2 (regulator G pro-
proteins present challenge understanding function. LRRK2          tein signaling 2), encodes GTPase-activating protein suggested bind different proteins, including            (GAP), statistically signiï¬ regulatory â€œhubâ€? path-
moesin, tubulin, MKK3, 6 7, JIP1, 3, 4, arfGAP1, arhGEF7,           ways linking LRRK2 DJ-1, PINK1, Parkin (Dusonchet
endoA, cyclin-GAK, rab5, rab7L1, 14-3-3, (Imai et al., 2008; Shin           et al., 2014). RGS2 particular prior
et al., 2008; Ko et al., 2009; Sancho et al., 2009; Gehrke et al., 2010;    studies indicate strong expression dopaminergic neurons. Hsu et al., 2010a,b; Kumar et al., 2010; Nichols et al., 2010; Chan         positioning RGS2 â€œhubâ€? multiple genes linked PD
et al., 2011; Matta et al., 2012; Stafa et al., 2012; Habig et al., 2013;   suggests key role RGS2 regulator LRRK2 activity,
Beilina et al., 2014). LRRK2 regulatory role wide variety        function neuronal toxicity (Dusonchet et al., 2014). RGS pro- biological processes;  protein translations, cytoskeletal        teins family proteins characterized GAP domain
processes, vesicular dynamics, neurite extension, mitochondrial             âˆ¼130 amino acids, RGS domain. GAP proteins
function, endoplasmic reticulum function, autophagy. Broad              associated LRRK2 function, including Arf-
proteomics studies point interactions multiple new pro-             GAP1 ArhGEF7 (Stafa et al., 2012; Xiong et al., 2012; Habig
teins, regulation mitochondrial lysosomal            et al., 2013). GAPs GTPase exchange factors (GEFs)
proteins (Di Domenico et al., 2012; Beilina et al., 2014). mul-         classically considered function regulating signaling tiple functions pathways associated LRRK2 suggest                G-protein coupled receptors, GAPs exhibit strong role
complex role LRRK2 neuronal biology. approached              regulating LRRK2 GTPase activity. Recombinant RGS2 question using systems biology create regulatory net-          ArhGEF7 increase GTPase activity immunopuriï¬?ed 
work outlines multiplicity functional interactions           length LRRK2 dose-dependent manner vitro. Recombinant
LRRK2 partners.                                                    RGS2 inhibits LRRK2 kinase activity dose-dependent
    employed silico approach elucidate gene reg-            manner.  concentration RGS2 required achieve
ulatory network linked LRRK2 (Dusonchet et al., 2014).              maximal inhibition LRRK2 kinase activity, occurs tenth
approach used network algorithm, termed context likelihood            concentration RGS2 required stimulate GTPase relatedness (CLR; Faith et al., 2007). algorithm designed        activity maximally. increasingly clear output analyze state-dependent genome-wide expression data based                LRRK2 modulated particular GAP GEF bound degree synchrony variation transcript levels           GAPs GEFs appear increase LRRK2 GTPase
samples.  transcripts expression varies concert          activity, RGS2 ArhGEF7 reduce LRRK2 kinase activ-
LRRK2 transcripts deemed neighbors. analyzed brain              ity, ArfGAP1 increases LRRK2 autophosphorylation (Stafa white blood cells; use white blood cells diversiï¬?ed path-        et al., 2012; Habig et al., 2013; Dusonchet et al., 2014). sug-
way representation away predominance genes linked                 gests output GTPase domain determine, 


Frontiers Molecular Neuroscience                             www.frontiersin.org                                July 2014 | Volume 7 | Article 64 | 4
Boon et al.                                                                                                        LRRK2 regulator cellular signaling



  particular GAP GEF associated                    CONCLUSION
(Figure 1).                                                                       LRRK2 large molecule molecular interactions. Mul-
                                                                                  tiple studies focused kinase activity, resulting
GAPs GEFs MODULATE CYTOSKELETAL EFFECTS                                    identiï¬?cation LRRK2 inhibitors therapeutic
LRRK2                                                                             beneï¬?t. function LRRK2 kinase activity remains unclear, putative role LRRK2 regulating cytoskeletal function                     LRRK2 itself robust substrate identiï¬?ed consistently appears literature. LRRK2 observed                   date.  LRRK2 shown interact regulate neurite outgrowth, tubulin microtubules, traf-                    different proteins, suggesting important function LRRK2
ï¬?cking proteins actin (Hsu et al., 2010b; Chan et al., 2011;                  lie domains linked indirectly kinase
Caesar et al., 2013; Law et al., 2014). studies suggest                  function. recent study suggests important action phos-
RGS2 inhibits tendency LRRK2 (WT G2019S)                            phorylation regulation LRRK2 degradation, reduce length complexity neuronal processes primary                     imply look kinase function understand
neurons (Figure 1; Dusonchet et al., 2014). expression                      role LRRK2 neuron (Skibinski et al., 2014). need
RGS2 LRRK2 signiï¬?cantly protects G2019S LRRK2-                       look kinase function emphasized examination induced neurite shortening, RGS2 effect                     actions GAPs GEFs LRRK2, proteins axonal length. ArhGEF7 increases LRRK2 GTPase activity                    exhibit seemingly similar actions LRRK2 kinase activity induces LRRK2 increase neuronal arborization, length                   elicit opposite actions regulation neurite outgrowth growth cone formation (Figure 1; Habig et al., 2013). contrast,                cytoskeletal function (Figure 1).
knockdown ArfGAP1 protects G2019S LRRK2-induced                            Studies laboratory laboratories iden-
neurite shortening (Figure 1; Stafa et al., 2012). ArhGEF7 acts                   tiï¬?ed numerous signaling molecules interact actin cytoskeleton, raises possibility                 LRRK2. interactions LRRK2 clearly pleiotropic, act tandem rac1 cdc42,                         vary depending cell type function investi-
bind LRRK2 (Chan et al., 2011; Habig et al., 2013). data                    gated. Despite complexity, distinct themes evolving,
suggest small GTPases regulatory proteins act                   themes potentially important implications regulate actions LRRK2 cytoskeleton neurite                     understanding pathophysiology PD. theme outgrowth (Figure 1). Redundant actions RGS2 ArhGEF7                       arises role LRRK2 regulating signaling cascades, neurite cytoskeletal activity unlikely, raises                 MAPK cascade. clear LRRK2 acts manner possibility RGS2 ArhGEF7 exhibit divergent effects                   different classic modulators MAPK cascade, LRRK2 examining functions, vesicular                        does directly stimulate phosphorylation MAP Kinases.
biology.                                                                          large size LRRK2 enables bind multiple different pro-
                                                                                  teins, potentially bring signaling scaffold,
                                                                                  analogous JIPs.
                                                                                      general theme occurring ï¬?eld PD regu-
                                                                                  lation vesicular transport. vast majority genes associated
                                                                                  PD function related membranes vesicles.
                                                                                  Î±-Synuclein thought regulate production small vesi-
                                                                                  cles promoting membrane curvature (Perlmutter et al., 2009;
                                                                                  Varkey et al., 2010; Ducas Rhoades, 2012). LRRK2 shows
                                                                                  strong interactions membranes thought modu-
                                                                                  late autophagy, involves vesicular dynamics. PINK1,
                                                                                  parkin, HTRA2 proteins regulate mitochondrial
                                                                                  function, possibly including mitophagy (Plun-Favreau et al., 2007;
                                                                                  Narendra et al., 2010). ATP13A2 GBA associated                                                                                   lysosomes (Mazzulli et al., 2011; Usenovic et al., 2012). consis-
                                                                                  tent appearance vesicular biology pathophysiology PD
                                                                                  suggests interactions LRRK2 vesicles likely 
                                                                                  tribute mechanism disease pathogenesis. Future studies
                                                                                  need speciï¬?cally investigate signaling pathways regu-
                                                                                  late interactions LRRK2 membranous organelles,                                                                                   autophagosomes. context, preliminary data 
  FIGURE 1 | Regulation LRRK2 output GTPase activity, GAPs              ing roles MAPK cascade regulating interactions   GEFs. RGS2 ArhGEF7 bind LRRK2 inhibit GTPase activity,
                                                                                  LRRK2 autophagic intriguing (Plowey et al.,
  inhibits LRRK2 kinase activity appears direct LRRK2
  increasing neuronal cytoskeletal activity. Rac1 small GTPase        2008).
  known regulate actin polymerase. Rac1 binds LRRK2 act            complexity LRRK2 signaling provide insight   concert LRRK2 increase cytoskeletal activity. contrast, binding   nature pathology associated LRRK2-mediated disease.
  ArfGAP1 LRRK2 increases autophosphorylation, appears   inhibit cytoskeletal activity.
                                                                                  cases LRRK2 mutations exhibit Î±-synuclein pathol-
                                                                                  ogy, Lewy bodies, cases exhibit tau pathology



Frontiers Molecular Neuroscience                                     www.frontiersin.org                             July 2014 | Volume 7 | Article 64 | 5
Boon et al.                                                                                                                                 LRRK2 regulator cellular signaling




(Devine Lewis, 2008). pathological heterogeneity                                    expression levels toxicity Parkinsonâ€™s disease: results GenePD
derive impact different disease processes LRRK2                                     Study. Hum. Mol. Genet. 20, 1478â€“1487. doi: 10.1093/hmg/ddr026
                                                                                                Dusonchet, J., Li, H., Guillily, M., Liu, M., Stafa, K., Derada, C., et al. (2014). biology, signaling cascades  MAPKs) promot-
                                                                                                   Parkinsonâ€™s disease gene regulatory network identiï¬?es signaling protein RGS2
ing tau pathology signaling cascades  vesicular                                  modulator LRRK2 activity neuronal toxicity. Hum. Mol. Genet. doi:
biology) promoting Î±-synuclein pathology.                                                          10.1093/hmg/ddu202 [Epub ahead print].
                                                                                                Dzamko, N., Deak, M., Hentati, F., Reith,  D., Prescott,  R., Alessi, D.
AUTHOR CONTRIBUTIONS                                                                               R., et al. (2010). Inhibition LRRK2 kinase activity leads dephosphoryla-
                                                                                                   tion Ser(910)/Ser(935), disruption 14-3-3 binding altered cytoplasmic
Joon Y. Boon drafted manuscript, Chelsea Trengrove                                             localization. Biochem. J. 430, 405â€“413. doi: 10.1042/BJ20100784
helped revisions, Benjamin Wolozin edited                                          Dzamko, N., Inesta-Vaquera, F., Zhang, J., Xie, C., Cai, H., Arthur, S., et al. (2012).
manuscript. Julien Dusonchet provided important concepts                                       IkappaB kinase family phosphorylates Parkinsonâ€™s disease kinase LRRK2 manuscript.                                                                                    Ser935 Ser910 Toll-like receptor signaling. PLoS 7:e39132.
                                                                                                   doi: 10.1371/journal.pone.0039132
                                                                                                Faith, J. J., Hayete, B., Thaden, J. T., Mogno, , Wierzbowski, J., Cottarel, G.,
ACKNOWLEDGMENTS                                                                                    et al. (2007). Large-scale mapping validation Escherichia coli transcrip- work supported grant award Benjamin Wolozin                                         tional regulation compendium expression proï¬?les. PLoS Biol. 5:e8. doi:
(NIH grants ES020395, NS066108, NS073679, NS060872,                                            10.1371/journal.pbio.0050008
BrightFocus Foundation, CurePSP Foundation                                          Ferree, , Guillily, M., Li, H., Smith, K., Takashima, , Squillace, R., et al. (2012).
                                                                                                   Regulation physiologic actions LRRK2: focus autophagy. Neurodegener.
Alzheimer Association).
                                                                                                   Dis. 10, 238â€“241. doi: 10.1159/000332599
                                                                                                Gallo, K. , Johnson, G. L. (2002). Mixed-lineage kinase control JNK REFERENCES                                                                                         p38 MAPK pathways. Nat. Rev. Mol. Cell Biol. 3, 663â€“672. doi: 10.1038/nrm906
Alegre-Abarrategui, J., Christian, H., Luï¬  M. M., Mutihac, R., Venda, L. L.,                 Gasser, T., Hardy, J., Mizuno, Y. (2011). Milestones PD genetics. Mov. Disord.
  Ansorge, O., et al. (2009). LRRK2 regulates autophagic activity localizes                 26, 1042â€“1048. doi: 10.1002/mds.23637
  speciï¬?c membrane microdomains novel human genomic reporter cellular                      Gehrke, S., Imai, Y., Sokol, N., Lu, B. (2010). Pathogenic LRRK2 negatively
  model. Hum. Mol. Genet. 18, 4022â€“4034. doi: 10.1093/hmg/ddp346                                   regulates microRNA-mediated translational repression. Nature 466, 637â€“641.
Bailey, R. M., Covy, J. P., Melrose, H. L., Rousseau, L., Watkinson, R., Knight, J., et al.        doi: 10.1038/nature09191
  (2013). LRRK2 phosphorylates novel tau epitopes promotes tauopathy. Acta                  Gloeckner, C. J., Schumacher, , Boldt, K., Uefï¬?ng, M. (2009). Parkinson
  Neuropathol. 126, 809â€“827. doi: 10.1007/s00401-013-1188-4                                        disease-associated protein kinase LRRK2 exhibits MAPKKK activity phos-
Beilina, , Rudenko,  N., Kaganovich, , Civiero, L., Chau, H., Kalia, S. K., et al.           phorylates MKK3/6 MKK4/7, vitro. J. Neurochem. 109, 959â€“968. doi:
  (2014). Unbiased screen interactors leucine-rich repeat kinase 2 supports               10.1111/j.1471-4159.2009.06024.x
  common pathway sporadic familial Parkinson disease. Proc. Natl. Acad.                 Greene, J. G. (2012). Current status future directions gene expression proï¬?ling
  Sci. U.S  111, 2626â€“2631. doi: 10.1073/pnas.1318306111                                         Parkinsonâ€™s disease. Neurobiol. Dis. 45 76â€“82. doi: 10.1016/j.nbd.2010.10.022
Berwick, D. C., Harvey, K. (2011). LRRK2 signaling pathways:                            Greggio, E., Cookson, M. R. (2009). Leucine-rich repeat kinase 2 muta-
  key unlocking neurodegeneration? Trends Cell Biol. 21, 257â€“265. doi:                          tions Parkinsonâ€™s disease: questions. ASN Neuro 1:e00002. doi:
  10.1016/j.tcb.2011.01.001                                                                        10.1042/AN20090007
Biskup, S., Moore, D. J., Celsi, F., Higashi, S., West,  B., Andrabi, S. , et al. (2006).   Greggio, E., Jain, S., Kingsbury, , Bandopadhyay, R., Lewis, P., Kaganovich,
  Localization LRRK2 membranous vesicular structures mammalian                        , et al. (2006). Kinase activity required toxic effects mutant
  brain. Ann. Neurol. 60, 557â€“569. doi: 10.1002/ana.21019                                          LRRK2/dardarin. Neurobiol. Dis. 23, 329â€“341. doi: 10.1016/j.nbd.2006.
Caesar, M., Zach, S., Carlson, C. B., Brockmann, K., Gasser, T., Gillardon, F.                 04.001
  (2013). Leucine-rich repeat kinase 2 functionally interacts microtubules             Habig, K., Gellhaar, S., Heim, B., Djuric, V., Giesert, F., Wurst, W., et al. (2013).
  kinase-dependently modulates cell migration. Neurobiol. Dis. 54, 280â€“288. doi:                   LRRK2 guides actin cytoskeleton growth cones ARHGEF7   10.1016/j.nbd.2012.12.019                                                                        Tropomyosin 4. Biochim. Biophys. Acta 1832, 2352â€“2367. doi: 10.1016/j.bbadis.
Carballo-Carbajal, , Weber-Endress, S., Rovelli, G., Chan, D., Wolozin, B., Klein, C.            2013.09.009
  L., et al. (2010). Leucine-rich repeat kinase 2 induces alpha-synuclein expression            Healy, D. G., Falchi, M., Oâ€™Sullivan, S. S., Bonifati, V., Durr, , Bressman, S., et al.
  extracellular signal-regulated kinase pathway. Cell Signal. 22, 821â€“827.                 (2008). International, Phenotype, genotype, worldwide genetic penetrance
  doi: 10.1016/j.cellsig.2010.01.006                                                               LRRK2-associated Parkinsonâ€™s disease: case-control study. Lancet Neurol. 7,
Chan, D., Citro, , Cordy, J. M., Shen, G. C., Wolozin, B. (2011). Rac1 protein               583â€“590. doi: 10.1016/S1474-4422(08)70117-0
  rescues neurite retraction caused G2019S leucine-rich repeat kinase 2 (LRRK2).             Ho, C. C., Rideout, H. J., Ribe, E., Troy, C. M., Dauer, W. T. (2009).   J. Biol. Chem. 286, 16140â€“16149. doi: 10.1074/jbc.M111.234005                                    Parkinson disease protein leucine-rich repeat kinase 2 transduces death signals
Cookson, M. R. (2010). role leucine-rich repeat kinase2 (LRRK2)                          Fas-associated protein death domain caspase-8 cellular model   Parkinsonâ€™s disease. Nat. Rev. Neurosci. 11, 791â€“797. doi: 10.1038/nrn2935                       neurodegeneration. J. Neurosci. 29, 1011â€“1016. doi: 10.1523/JNEUROSCI.5175-
Dawson, T. M., Ko, H. S., Dawson, V. L. (2010). Genetic animal mod-                            08.2009
  els Parkinsonâ€™s disease. Neuron 66, 646â€“661. doi: 10.1016/j.neuron.2010.                   Hsu, C. H., Chan, D., Greggio, E., Saha, S., Guillily, M. D., Ferree, , et al.
  04.034                                                                                           (2010a). MKK6 binds regulates expression Parkinsonâ€™s disease-related
Devine, M. J., Lewis, P.  (2008). Emerging pathways genetic Parkin-                       protein LRRK2. J. Neurochem. 112, 1593â€“604. doi: 10.1111/j.1471-4159.2010.
  sonâ€™s disease: tangles, Lewy bodies LRRK2. FEBS J. 275, 5748â€“5757. doi:                      06568.x
  10.1111/j.1742-4658.2008.06707.x                                                              Hsu, C. H., Chan, D., Wolozin, B. (2010b). LRRK2 stress response:
Di Domenico, F., Sultana, R., Ferree, , Smith, K., Barone, E., Perluigi, M., et al.              interaction MKKs JNK-interacting proteins. Neurodegener. Dis. 7, 68â€“
  (2012). Redox proteomics analyses inï¬‚uence expression wild-                      75. doi: 10.1159/000285509
  type mutated LRRK2 tau C. elegans protein expression oxidative                  Imai, Y., Gehrke, S., Wang, H. Q., Takahashi, R., Hasegawa, K., Oota, E., et al. (2008).
  modiï¬?cation: relevance Parkinson disease. Antioxid. Redox Signal. 17, 1490â€“                   Phosphorylation 4E-BP LRRK2 affects maintenance dopamin-
  1506. doi: 10.1089/ars.2011.4312                                                                 ergic neurons Drosophila. EMBO J. 27, 2432â€“2443. doi: 10.1038/emboj.
Ducas, V. C., Rhoades, E. (2012). Quantifying interactions beta-synuclein                   2008.163
  gamma-synuclein model membranes. J. Mol. Biol. 423, 528â€“539. doi:                    Ito, G., Okai, T., Fujino, G., Takeda, K., Ichijo, H., Katada, T., et al. (2007). GTP bind-
  10.1016/j.jmb.2012.08.008                                                                        ing essential protein kinase activity LRRK2, causative gene product
Dumitriu, , Pacheco, C. D., Wilk, J. B., Strathearn, K. E., Latourelle, J. C., Gold-             familial Parkinsonâ€™s disease. Biochemistry 46, 1380â€“1388. doi: 10.1021/
  wurm, S., et al. (2011). Cyclin-G-associated kinase modiï¬?es alpha-synuclein                      bi061960m



Frontiers Molecular Neuroscience                                               www.frontiersin.org                                             July 2014 | Volume 7 | Article 64 | 6
Boon et al.                                                                                                                           LRRK2 regulator cellular signaling




Kelkar, N., Standen, C. L., Davis, R. J. (2005). Role JIP4 scaffold protein   Parisiadou, L., Xie, C., Cho, H. J., Lin, X., Gu, X. L., Long, C. X., et al. (2009).
   regulation mitogen-activated protein kinase signaling pathways. Mol. Cell.          Phosphorylation ezrin/radixin/moesin proteins LRRK2 promotes rear-
   Biol. 25, 2733â€“2743. doi: 10.1128/MCB.25.7.2733-2743.2005                                  rangement actin cytoskeleton neuronal morphogenesis. J. Neurosci. 29,
Ko, H. S., Bailey, R., Smith, W. W., Liu, , Shin, J. H., Lee, Y. , et al. (2009).         13971â€“13980. doi: 10.1523/JNEUROSCI.3799-09.2009
   CHIP regulates leucine-rich repeat kinase-2 ubiquitination, degradation,             Parisiadou, L., Yu, J., Sgobio, C., Xie, C., Liu, G., Sun, L., et al. (2014).
   toxicity. Proc. Natl. Acad. Sci. U.S  106, 2897â€“2902. doi: 10.1073/pnas.0810             LRRK2 regulates synaptogenesis dopamine receptor activation    123106                                                                                     modulation PKA activity. Nat. Neurosci. 17, 367â€“376. doi: 10.1038/
Kumar, , Greggio, E., Beilina, , Kaganovich, , Chan, D., Taymans, J. M., et al.         nn.3636
   (2010). Parkinsonâ€™s disease associated LRRK2 exhibits weaker vitro phos-          Perlmutter, J. D., Braun,  R., Sachs, J. N. (2009). Curvature dynamics
   phorylation 4E-BP compared autophosphorylation. PLoS 5:e8730. doi:               alpha-synuclein familial Parkinson disease mutants: molecular simulations
   10.1371/journal.pone.0008730                                                               micelle- bilayer-bound forms. J. Biol. Chem. 284, 7177â€“7189. doi:
Law, B. M., Spain, V. , Leinster, V. H., Chia, R., Beilina, , Cho, H. J., et al.          10.1074/jbc.M808895200
   (2014). direct interaction leucine-rich repeat kinase 2 speciï¬?c            Plowey, E. D., Cherra, S. J. III, Liu, Y. J., Chu, C. T. (2008). Role    beta-tubulin isoforms regulates tubulin acetylation. J. Biol. Chem. 289, 895â€“908.          autophagy G2019S-LRRK2-associated neurite shortening differentiated
   doi: 10.1074/jbc.M113.507913                                                               SH-SY5Y cells. J. Neurochem. 105, 1048â€“1056. doi: 10.1111/j.1471-4159.2008.
Lees,  J., Hardy, J., Revesz, T. (2009). Parkinsonâ€™s disease. Lancet 373, 2055â€“         05217.x
   2066. doi: 10.1016/S0140-6736(09)60492-X                                                 Plun-Favreau, H., Klupsch, K., Moisoi, N., Gandhi, S., Kjaer, S., Frith, D.,
Lewis, P. , Greggio, E., Beilina, , Jain, S., Baker, , Cookson,                     et al. (2007). mitochondrial protease HtrA2 regulated Parkinsonâ€™s
   M. R. (2007). R1441C mutation LRRK2 disrupts GTP hydrolysis.                        disease-associated kinase PINK1. Nat. Cell Biol. 9, 1243â€“1252. doi: 10.1038/
   Biochem. Biophys. Res. Commun. 357, 668â€“671. doi: 10.1016/j.bbrc.2007.                     ncb1644
   04.006                                                                                   Saha, S., Guillily, M. D., Ferree, , Lanceta, J., Chan, D., Ghosh, J., et al. (2009).
Li, X., Tan, Y. C., Poulose, S., Olanow, C. W., Huang, X. Y., Yue,  (2007).             LRRK2 modulates vulnerability mitochondrial dysfunction Caenorhab-
   Leucine-rich repeat kinase 2 (LRRK2)/PARK8 possesses GTPase activity               ditis elegans. J. Neurosci. 29, 9210â€“9218. doi: 10.1523/JNEUROSCI.2281-
   altered familial Parkinsonâ€™s disease R1441C/G mutants. J. Neurochem. 103,               09.2009
   238â€“247.                                                                                 Samann, J., Hegermann, J., von Gromoff, E., Eimer, S., Baumeister, R., Schmidt,
Liou,  K., Leak, R. K., Li, L., Zigmond, M. J. (2008). Wild-type LRRK2              E. (2009). Caenorhabditits elegans LRK-1 PINK-1 act antagonistically    mutant attenuates stress-induced cell death ERK pathway. Neurobiol.            stress response neurite outgrowth. J. Biol. Chem. 284, 16482â€“16491. doi:
   Dis. 32, 116â€“124. doi: 10.1016/j.nbd.2008.06.016                                           10.1074/jbc.M808255200
Liu, , Lee, J., Krummey, S., Lu, W., Cai, H., Lenardo, M. J. (2011).              Sancho, R. M., Law, B. M., Harvey, K. (2009). Mutations LRRK2 Roc-
   kinase LRRK2 regulator transcription factor NFAT modulates                COR tandem domain link Parkinsonâ€™s disease Wnt signalling pathways. Hum.
   severity inï¬‚ammatory bowel disease. Nat. Immunol. 12, 1063â€“1070. doi:               Mol. Genet. 18, 3955â€“3968. doi: 10.1093/hmg/ddp337
   10.1038/ni.2113                                                                          Shin, N., Jeong, H., Kwon, J., Heo, H. Y., Kwon, J. J., Yun, H. J., et al. (2008).
Liu, , Wang, X., Yu, Y., Li, X., Wang, T., Jiang, H., et al. (2008). Drosophila model     LRRK2 regulates synaptic vesicle endocytosis. Exp. Cell Res. 314, 2055â€“2065. doi:
   LRRK2-linked parkinsonism. Proc. Natl. Acad. Sci. U.S  105, 2693â€“2698.               10.1016/j.yexcr.2008.02.015
   doi: 10.1073/pnas.0708452105                                                             Simon-Sanchez, J., Herranz-Perez, V., Olucha-Bordonau, F., Perez-Tur, J.
Macleod, D., Dowman, J., Hammond, R., Leete, T., Inoue, K., Abe-                          (2006). LRRK2 expressed areas affected Parkinsonâ€™s disease adult
   liovich,  (2006). familial parkinsonism gene LRRK2 regulates neu-                    mouse brain. Eur. J. Neurosci. 23, 659â€“666. doi: 10.1111/j.1460-9568.2006.
   rite process morphology. Neuron 52, 587â€“593. doi: 10.1016/j.neuron.2006.                   04616.x
   10.008                                                                                   Skibinski, G., Nakamura, K., Cookson, M. R., Finkbeiner, S. (2014).
Marin,  (2008). Ancient origin Parkinson disease gene LRRK2. J. Mol. Evol.           Mutant LRRK2 toxicity neurons depends LRRK2 levels synuclein
   67, 41â€“50. doi: 10.1007/s00239-008-9122-4                                                  kinase activity inclusion bodies. J. Neurosci. 34, 418â€“433. doi:
Martin, , Kim, J. W., Lee, B. D., Kang, H. C., Xu, J. C., Jia, H., et al.                   10.1523/JNEUROSCI.2712-13.2014
   (2014). Ribosomal protein s15 phosphorylation mediates LRRK2 neurode-                    Smith, W. W., Pei, , Jiang, H., Moore, D. J., Liang, Y., West,  B., et al. (2005).
   generation Parkinsonâ€™s disease. Cell 157, 472â€“485. doi: 10.1016/j.cell.2014.            Leucine-rich repeat kinase 2 (LRRK2) interacts parkin mutant LRRK2
   01.064                                                                                     induces neuronal degeneration. Proc. Natl. Acad. Sci. U.S  102, 18676â€“18681.
Matta, S., Van Kolen, K., da Cunha, R., van den Bogaart, G., Mandemakers, W.,                 doi: 10.1073/pnas.0508052102
   Miskiewicz, K., et al. (2012). LRRK2 controls EndoA phosphorylation cycle          Stafa, K., Trancikova, , Webber, P. J., Glauser, L., West,  B., Moore,
   synaptic endocytosis. Neuron 75, 1008â€“1021. doi: 10.1016/j.neuron.2012.08.022              D. J. (2012). GTPase activity neuronal toxicity Parkinsonâ€™s disease-
Mazzulli, J. R., Xu, Y. H., Sun, Y., Knight,  L., McLean, P. J., Caldwell, G.               associated LRRK2 regulated ArfGAP1. PLoS Genet. 8:e1002526. doi:
   , et al. (2011). Gaucher disease glucocerebrosidase alpha-synuclein form             10.1371/journal.pgen.1002526
   bidirectional pathogenic loop synucleinopathies. Cell 146, 37â€“52. doi:              Taylor, J. P., Mata,  F., Farrer, M. J. (2006). LRRK2: common pathway    10.1016/j.cell.2011.06.001                                                                 parkinsonism, pathogenesis prevention? Trends Mol. Med. 12, 76â€“82. doi:
Muda, K., Bertinetti, D., Gesellchen, F., Hermann, J. S., von Zweydorf, F., Geerlof,          10.1016/j.molmed.2005.12.004
   , et al. (2014). LRRK2 mutation R1441C/G/H impairs PKA phosphorylation              Tong, Y., Yamaguchi, H., Giaime, E., Boyle, S., Kopan, R., Kelleher, R. J. III, et al.
   LRRK2 disrupts interaction 14-3-3. Proc. Natl. Acad. Sci. U.S  111,         (2010). Loss leucine-rich repeat kinase 2 causes impairment protein degra-
   E34â€“E43. doi: 10.1073/pnas.1312701111                                                      dation pathways, accumulation alpha-synuclein, apoptotic cell death Narendra, D. P., Jin, S. M., Tanaka, , Suen, D. F., Gautier, C. , Shen,                   aged mice. Proc. Natl. Acad. Sci. U.S  107, 9879â€“9884. doi: 10.1073/pnas.
   J., et al. (2010). PINK1 selectively stabilized impaired mitochon-                   1004676107
   dria activate Parkin. PLoS Biol. 8:e1000298. doi: 10.1371/journal.pbio.               Usenovic, M., Knight,  L., Ray, , Wong, V., Brown, K. R., Caldwell, G.
   1000298                                                                                    , et al. (2012). Identiï¬?cation novel ATP13A2 interactors role Nichols, R. J., Dzamko, N., Morrice, N. , Campbell, D. G., Deak, M., Ordureau,              alpha-synuclein misfolding toxicity. Hum. Mol. Genet. 21, 3785â€“3794. doi:
   , et al. (2010). 14-3-3 binding LRRK2 disrupted multiple Parkinsonâ€™s            10.1093/hmg/dds206
   disease-associated mutations regulates cytoplasmic localization. Biochem. J.         Varkey, J., Isas, J. M., Mizuno, N., Jensen, M. B., Bhatia, V. K., Jao, C. C.,
   430, 393â€“404. doi: 10.1042/BJ20100483                                                      et al. (2010). Membrane curvature induction tubulation common fea-
Pankratz, N., Wilk, J. B., Latourelle, J. C., DeStefano,  L., Halter, C., Pugh, E. W.,      tures synucleins apolipoproteins. J. Biol. Chem. 285, 32486â€“32493. doi:
   et al. (2009). Molecular genetic, genomewide association study susceptibility          10.1074/jbc.M110.139576
   genes contributing familial Parkinson disease. Hum. Genet. 124, 593â€“605. doi:         Venderova, K., Kabbach, G., Abdel-Messih, E., Zhang, Y., Parks, R. J., Imai, Y., et al.
   10.1007/s00439-008-0582-9                                                                  (2009). Leucine-rich repeat kinase 2 interacts Parkin, DJ-1 PINK-1 



Frontiers Molecular Neuroscience                                           www.frontiersin.org                                           July 2014 | Volume 7 | Article 64 | 7
Boon et al.                                                                                                                            LRRK2 regulator cellular signaling




  Drosophila melanogaster model Parkinsonâ€™s disease. Hum. Mol. Genet. 18,            Yao, C., El Khoury, R., Wang, W., Byrd, T. , Pehek, E. ,
  4390â€“4404. doi: 10.1093/hmg/ddp394                                                        Thacker, C., et al. (2010). LRRK2-mediated neurodegeneration dys-
Verhey, K. J., Meyer, D., Deehan, R., Blenis, J., Schnapp, B. J., Rapoport, T. ,          function dopaminergic neurons Caenorhabditis elegans model   et al. (2001). Cargo kinesin identiï¬?ed JIP scaffolding proteins asso-      